GCMUX
Price
$42.64
Change
+$0.18 (+0.42%)
Updated
Aug 14 closing price
Net Assets
1.21B
VIMSX
Price
$92.26
Change
+$0.25 (+0.27%)
Updated
Aug 14 closing price
Net Assets
224.68B
Interact to see
Advertisement

GCMUX vs VIMSX

GCMUX vs VIMSX Comparison Chart in %
View a ticker or compare two or three
VS
GCMUX vs. VIMSX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GCMUX is a Buy and VIMSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIMSX has more cash in the bank: 225B vs. GCMUX (1.21B). VIMSX pays higher dividends than GCMUX: VIMSX (1.20) vs GCMUX (0.92). GCMUX was incepted earlier than VIMSX: GCMUX (11 years) vs VIMSX (28 years). GCMUX (0.83) is less costly to investors than VIMSX (0.17). GCMUX is a more actively managed with annual turnover of: 73.00 vs. VIMSX (16.00). VIMSX has a lower initial minimum investment than GCMUX: VIMSX (3000) vs GCMUX (5000000). VIMSX annual gain was more profitable for investors over the last year : 17.83 vs. GCMUX (11.32). VIMSX return over 5 years is better than : 39.25 vs. GCMUX (-0.82).
GCMUXVIMSXGCMUX / VIMSX
Total Expense Ratio0.830.17488%
Annual Report Gross Expense Ratio0.830.17488%
Fund Existence11 years28 years-
Gain YTD21.38416.209132%
Front LoadN/AN/A-
Min. Initial Investment50000003000166,667%
Min. Initial Investment IRAN/AN/A-
Net Assets1.21B225B1%
Annual Yield % from dividends0.921.2077%
Returns for 1 year11.3217.8363%
Returns for 3 years28.4955.5051%
Returns for 5 years-0.8239.25-2%
Returns for 10 years30.76165.8719%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MGRRX42.34N/A
N/A
MFS International Growth R1
SSPIX115.71N/A
N/A
SEI S&P 500 Index F (SIMT)
TPYCX9.06N/A
N/A
Touchstone Sands Capital Intl Gr Eq C
FASEX63.90N/A
N/A
Nuveen Mid Cap Value Opportunities A
BMSTX18.24N/A
N/A
MFS Blended Research Mid Cap Eq R3